ConforMIS announced preliminary 4Q17 revenue of US $20.8MM, -4.0% vs. 4Q16, and 2017 revenue of $78.1MM, -2.0% vs. 2016.
For 2018, leadership offered revenue guidance in a range of $79.6MM to $83.6MM.
Final financial results will be published on February 7, 2018.
The company has released its first study results of the year, sharing analysis from independent, prospective study of the iTotal CR Knee in the restoration of coronal plane mechanical axis alignment. The results suggest that use of a patient-specific custom knee plus patient-specific instrumentation yields more consistently-accurate results than those found with use of patient-specific cutting guides and off-the-shelf implants.
ConforMIS announced preliminary 4Q17 revenue of US $20.8MM, -4.0% vs. 4Q16, and 2017 revenue of $78.1MM, -2.0% vs. 2016.
For 2018, leadership offered revenue guidance in a range of $79.6MM to $83.6MM.
Final financial results will be published on February 7, 2018.
The company has released its first study results of the year, sharing...
ConforMIS announced preliminary 4Q17 revenue of US $20.8MM, -4.0% vs. 4Q16, and 2017 revenue of $78.1MM, -2.0% vs. 2016.
For 2018, leadership offered revenue guidance in a range of $79.6MM to $83.6MM.
Final financial results will be published on February 7, 2018.
The company has released its first study results of the year, sharing analysis from independent, prospective study of the iTotal CR Knee in the restoration of coronal plane mechanical axis alignment. The results suggest that use of a patient-specific custom knee plus patient-specific instrumentation yields more consistently-accurate results than those found with use of patient-specific cutting guides and off-the-shelf implants.
Copy to clipboard 
